ATOSSA THERAPEUTICS, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $1.76 thousand for the 12-month period ending 2015-12-31, per its 10-K/A filed 2017-03-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $470.00.
- ATOSSA THERAPEUTICS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $1.76K.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2015-12-31 | $1.76K 10-K/A · filed 2017-03-21 | |||
| 2015-03-31 | $470.00 10-Q · filed 2015-05-13 | |||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-13 | |||
| 2013-09-30 | $4.41K 10-Q · filed 2014-11-12 | $210.00K derived: sum of 2 quarters · filed 2014-11-12 | $223.44K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $205.59K 10-Q · filed 2014-08-12 | $219.03K 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |